Difference between revisions of "Remifentanil"
From WikiAnesthesia
Chris Rishel (talk | contribs) m |
Sydney Caley (talk | contribs) (Added pharmacokinetic information in summary box) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 8: | Line 8: | ||
| routes = Intravenous | | routes = Intravenous | ||
| dosage = | | dosage = | ||
| dosage_calculation = remifentanil | |||
| mechanism = μ-opioid agonism | | mechanism = μ-opioid agonism | ||
| adverse_effects = | | adverse_effects = | ||
| time_onset = | | time_onset = | ||
| duration = | | duration = | ||
| metabolism = | | metabolism = Rapid Ester Hydrolysis by Nonspecic Esterases | ||
| halflife_redistribution = | | halflife_redistribution = 3 minutes | ||
| halflife_elimination = | | halflife_elimination = 10 minutes | ||
| clearance = | | clearance = | ||
| protein_binding = | | protein_binding = | ||
Latest revision as of 12:09, 22 December 2022
Remifentanil
| Trade names |
Ultiva |
|---|---|
 | |
| Clinical data | |
| Drug class |
Opioid |
| Uses |
Analgesia |
| Routes of administration |
Intravenous |
| Dosage | |
| Pharmacodynamics | |
| Mechanism of action |
μ-opioid agonism |
| Pharmacokinetics | |
| Metabolism |
Rapid Ester Hydrolysis by Nonspecic Esterases |
| Redistribution half-life |
3 minutes |
| Elimination half-life |
10 minutes |
| Physical and chemical data | |
| Article quality | |
| Editor rating | |
| User likes | 0 |
Provide a brief summary of this drug here.
Uses
Contraindications
Absolute contraindications
Precautions
Pharmacology
Pharmacodynamics
Mechanism of action
Adverse effects
Pharmacokinetics
Chemistry and formulation
History
References
Top contributors: Olivia Sutton, Chris Rishel and Sydney Caley